Partners Lisa Noller and Chris Donovan were quoted in a Law360 article, “Health Care Cases To Watch In 2020,” about a pending False Claims Act case over alleged fraud by hospice chain AseraCare Inc.
Noting that a federal judge had recently rejected a government bid to reopen discovery in the case, Noller, who chairs the firm’s national Government Enforcement Defense & Investigations Practice, said that “[w]ithout significant additional evidence, the case will be an uphill battle at trial.”
Donovan said health care providers facing similar FCA cases with inherently subjective diagnoses will now be pondering how they can “align those scenarios to the AseraCare case.”
People
Related News
08 May 2024
In the News
Benjamin Dryden on Noncompete Ban – Expect Trade Secret Litigation Increase in ‘Volume and Nastiness’
Foley & Lardner LLP partner Benjamin Dryden offered insight on the specific impact to the manufacturing sector of the U.S. Federal Trade Commission’s (FTC) recently issued final rule banning noncompete agreements
08 May 2024
In the News
Foley Real Estate, Hospitality Transactions Highlighted in Golf Inc.
Foley & Lardner LLP served as legal advisor on two of Golf Inc.’s Top 10 Sales of 2023.
08 May 2024
In the News
Kyle Faget Assesses FDA Rule Regulating Lab-Developed Tests, Potential Challenges
Foley & Lardner LLP partner Kyle Faget offers insight on potential challenges to the U.S. Food and Drug Administration’s (FDA) final rule regulating lab-developed tests (LDTs)